157 related articles for article (PubMed ID: 21413183)
21. Multifunctional superparamagnetic nanocarriers with folate-mediated and pH-responsive targeting properties for anticancer drug delivery.
Guo M; Que C; Wang C; Liu X; Yan H; Liu K
Biomaterials; 2011 Jan; 32(1):185-94. PubMed ID: 21067808
[TBL] [Abstract][Full Text] [Related]
22. Nanomedicine strategies for molecular targets with MRI and optical imaging.
Pan D; Caruthers SD; Chen J; Winter PM; SenPan A; Schmieder AH; Wickline SA; Lanza GM
Future Med Chem; 2010 Mar; 2(3):471-90. PubMed ID: 20485473
[TBL] [Abstract][Full Text] [Related]
23. Superparamagnetic nanovector with anti-cancer properties: gamma Fe2O3@Zoledronate.
Benyettou F; Lalatonne Y; Sainte-Catherine O; Monteil M; Motte L
Int J Pharm; 2009 Sep; 379(2):324-7. PubMed ID: 19457625
[TBL] [Abstract][Full Text] [Related]
24. Smart drug delivery through DNA/magnetic nanoparticle gates.
Ruiz-Hernández E; Baeza A; Vallet-Regí M
ACS Nano; 2011 Feb; 5(2):1259-66. PubMed ID: 21250653
[TBL] [Abstract][Full Text] [Related]
25. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
[TBL] [Abstract][Full Text] [Related]
26. Iron oxide nanoparticles for targeted cancer imaging and diagnostics.
Rosen JE; Chan L; Shieh DB; Gu FX
Nanomedicine; 2012 Apr; 8(3):275-90. PubMed ID: 21930108
[TBL] [Abstract][Full Text] [Related]
27. Specific targeting of cancer cells by multifunctional mitoxantrone-conjugated magnetic nanoparticles.
Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Coukos G; Omidi Y
J Drug Target; 2013 May; 21(4):328-40. PubMed ID: 23293842
[TBL] [Abstract][Full Text] [Related]
28. A smart magnetic nanoplatform for synergistic anticancer therapy: manoeuvring mussel-inspired functional magnetic nanoparticles for pH responsive anticancer drug delivery and hyperthermia.
Sasikala AR; GhavamiNejad A; Unnithan AR; Thomas RG; Moon M; Jeong YY; Park CH; Kim CS
Nanoscale; 2015 Nov; 7(43):18119-28. PubMed ID: 26471016
[TBL] [Abstract][Full Text] [Related]
29. Tailored functionalization of iron oxide nanoparticles for MRI, drug delivery, magnetic separation and immobilization of biosubstances.
Hola K; Markova Z; Zoppellaro G; Tucek J; Zboril R
Biotechnol Adv; 2015 Nov; 33(6 Pt 2):1162-76. PubMed ID: 25689073
[TBL] [Abstract][Full Text] [Related]
30. Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel/SPIO-loaded nanoparticles for tumor imaging and therapy.
Schleich N; Po C; Jacobs D; Ucakar B; Gallez B; Danhier F; Préat V
J Control Release; 2014 Nov; 194():82-91. PubMed ID: 25178270
[TBL] [Abstract][Full Text] [Related]
31. Preparation of Porous γ-Fe2O3@mWO3 Multifunctional Nanoparticles for Drug Loading and Controlled Release.
Peng H; Huang Q; Wu T; Wen J; He H
Curr Drug Deliv; 2018 Feb; 15(2):278-285. PubMed ID: 28240176
[TBL] [Abstract][Full Text] [Related]
32. [Research progress on application of gold magnetic nanocomposite in biomedicine].
Xue Y; Zhao L; Tang J; Yao C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2014 Apr; 31(2):462-6. PubMed ID: 25039160
[TBL] [Abstract][Full Text] [Related]
33. An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery.
Mitra RN; Doshi M; Zhang X; Tyus JC; Bengtsson N; Fletcher S; Page BD; Turkson J; Gesquiere AJ; Gunning PT; Walter GA; Santra S
Biomaterials; 2012 Feb; 33(5):1500-8. PubMed ID: 22078810
[TBL] [Abstract][Full Text] [Related]
34. Magnetic nanoparticles for drug delivery applications.
Namdeo M; Saxena S; Tankhiwale R; Bajpai M; Mohan YM; Bajpai SK
J Nanosci Nanotechnol; 2008 Jul; 8(7):3247-71. PubMed ID: 19051873
[TBL] [Abstract][Full Text] [Related]
35. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo.
Yu MK; Jeong YY; Park J; Park S; Kim JW; Min JJ; Kim K; Jon S
Angew Chem Int Ed Engl; 2008; 47(29):5362-5. PubMed ID: 18551493
[No Abstract] [Full Text] [Related]
36. Construction of iron oxide nanoparticle-based hybrid platforms for tumor imaging and therapy.
Hu Y; Mignani S; Majoral JP; Shen M; Shi X
Chem Soc Rev; 2018 Mar; 47(5):1874-1900. PubMed ID: 29376542
[TBL] [Abstract][Full Text] [Related]
37. Preparation and characterization of a magnetic and optical dual-modality molecular probe.
Bumb A; Regino CA; Perkins MR; Bernardo M; Ogawa M; Fugger L; Choyke PL; Dobson PJ; Brechbiel MW
Nanotechnology; 2010 Apr; 21(17):175704. PubMed ID: 20368682
[TBL] [Abstract][Full Text] [Related]
38. Magnetic nanoparticles-based diagnostics and theranostics.
Cohen Y; Shoushan SY
Curr Opin Biotechnol; 2013 Aug; 24(4):672-81. PubMed ID: 23415743
[TBL] [Abstract][Full Text] [Related]
39. Pharmaceutical formulation of HSA hybrid coated iron oxide nanoparticles for magnetic drug targeting.
Zaloga J; Pöttler M; Leitinger G; Friedrich RP; Almer G; Lyer S; Baum E; Tietze R; Heimke-Brinck R; Mangge H; Dörje F; Lee G; Alexiou C
Eur J Pharm Biopharm; 2016 Apr; 101():152-62. PubMed ID: 26854862
[TBL] [Abstract][Full Text] [Related]
40. Targeted delivery of multifunctional magnetic nanoparticles.
McCarthy JR; Kelly KA; Sun EY; Weissleder R
Nanomedicine (Lond); 2007 Apr; 2(2):153-67. PubMed ID: 17716118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
